Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.
暂无分享，去创建一个
A. Oza | H. Hirte | S. Lheureux | N. Dhani | J. Wright | S. Welch | M. Method | K. Matsuo | M. Butler | M. Cristea | J. Hurteau | C. Johnston | A. Mehta | Susie Tan | W. Jiménez | Erica M Stringer | Julie Burnier | A. Jain | Lisa Wang | J. Quintos